Agilent to Debut New CGH and SNP Arrays to Support Cyto, Cancer Research

The addition of SNP content will further enable cytogeneticists using Agilent arrays to detect constitutional abnormalities, and could help make Agilent more competitive against firms like Affymetrix and Illumina that currently sell SNP platforms for cytogenetic research.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.